[
    [
        {
            "time": "2019-01-29",
            "original_text": "Health Care Sector Update for 01/29/2019: JNJ,CGC,WEED.TO,BIIB,AGN",
            "features": {
                "keywords": [
                    "Health",
                    "Care",
                    "Sector",
                    "Update",
                    "JNJ",
                    "BIIB",
                    "AGN"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "Correlation": 8,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 4,
                "Duration": 3,
                "Entity_Density": 9,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 4,
                "Source_Recency": 7
            }
        },
        {
            "time": "2019-01-29",
            "original_text": "Biogen (BIIB) Q4 Earnings Beat Estimates, Revenues Up Y/Y",
            "features": {
                "keywords": [
                    "Biogen",
                    "Q4",
                    "Earnings",
                    "Beat",
                    "Estimates",
                    "Revenues",
                    "Up"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2019-01-29",
            "original_text": "U.S. senator asks J&J for documents on talc, baby powder safety",
            "features": {
                "keywords": [
                    "U.S.",
                    "senator",
                    "asks",
                    "J&J",
                    "documents",
                    "talc",
                    "baby",
                    "powder",
                    "safety"
                ],
                "sentiment_score": -0.7,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 7,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "2019-01-29",
            "original_text": "The Zacks Analyst Blog Highlights: Johnson & Johnson, Boeing, Starbucks, Norfolk and Prologis",
            "features": {
                "keywords": [
                    "Zacks",
                    "Analyst",
                    "Blog",
                    "Highlights",
                    "Johnson",
                    "&",
                    "Johnson",
                    "Boeing",
                    "Starbucks",
                    "Norfolk",
                    "Prologis"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare",
                    "industrials",
                    "consumer goods",
                    "real estate"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 5,
                "Impact": 4,
                "Duration": 4,
                "Entity_Density": 8,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 5,
                "Source_Recency": 6
            }
        },
        {
            "time": "2019-01-29",
            "original_text": "AbbVie's Imbruvica Combo Gets FDA Nod in First-Line Setting",
            "features": {
                "keywords": [
                    "AbbVie",
                    "Imbruvica",
                    "Combo",
                    "Gets",
                    "FDA",
                    "Nod",
                    "First-Line",
                    "Setting"
                ],
                "sentiment_score": 0.8,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 7,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2019-01-29",
            "original_text": "Pfizer (PFE) Q4 Earnings Beat, 2019 View Tepid, Stock Dips",
            "features": {
                "keywords": [
                    "Pfizer",
                    "Q4",
                    "Earnings",
                    "Beat",
                    "2019",
                    "View",
                    "Tepid",
                    "Stock",
                    "Dips"
                ],
                "sentiment_score": -0.3,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "Correlation": 9,
                "Sentiment": 4,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2019-01-29",
            "original_text": "Health Care Sector Update for 01/29/2019: ARAY, TRVN, ABBV, JNJ, PFE, ABT, MRK, AMGN",
            "features": {
                "keywords": [
                    "Health",
                    "Care",
                    "Sector",
                    "Update",
                    "ARAY",
                    "TRVN",
                    "ABBV",
                    "JNJ",
                    "PFE",
                    "ABT",
                    "MRK",
                    "AMGN"
                ],
                "sentiment_score": 0.4,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "Correlation": 8,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 4,
                "Duration": 3,
                "Entity_Density": 9,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 4,
                "Source_Recency": 7
            }
        },
        {
            "time": "2019-01-29",
            "original_text": "3 Stocks Warren Buffett Might Sell Next",
            "features": {
                "keywords": [
                    "Stocks",
                    "Warren",
                    "Buffett",
                    "Might",
                    "Sell",
                    "Next"
                ],
                "sentiment_score": -0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "various"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "Correlation": 6,
                "Sentiment": 3,
                "Importance": 5,
                "Impact": 4,
                "Duration": 4,
                "Entity_Density": 5,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 6
            }
        },
        {
            "time": "2019-01-29",
            "original_text": "Johnson & Johnson (JNJ) Gains As Market Dips: What You Should Know",
            "features": {
                "keywords": [
                    "Johnson",
                    "&",
                    "Johnson",
                    "Gains",
                    "Market",
                    "Dips"
                ],
                "sentiment_score": 0.2,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "Correlation": 8,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 7,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 5,
                "Source_Recency": 7
            }
        }
    ]
]